News / Press Releases
QA Solution for Prostate Brachytherapy
Computerized Imaging Reference Systems, Inc.
2428 Almeda Avenue
Norfolk, VA 23513
Toll Free (800) 617-1177
Phone (757) 855-2765
Fax (757) 857-0523
FOR IMMEDIATE RELEASE
Quality Assurance Solution for Prostate Brachytherapy
Norfolk, Virginia (February 13, 2009) CIRS is pleased to announce that the CIRS Model 045 Brachytherapy QA Phantom used in conjunction with the CIRS Model 053G Ultrasound Prostate Phantom offers a complete solution for implementing a QA program specific to transrectal ultrasound used for guidance of prostate brachytherapy as recommended by AAPM Task Group 1281.
The Model 045 is designed to enable users to check key imaging parameters such as: depth of penetration, axial and lateral resolution, distance measurements, area measurements, volume measurements and geometric consistency with the treatment planning computer.
The Model 053G is a disposable product ideal for practicing seed implantations and can be used to verify alignment of the physical needle template with the electronic grid.
CIRS, a Castleray company, is recognized worldwide for tissue simulation technology and is the leader in the manufacture of phantoms and simulators for quantitative densitometry, calibration, quality control and research in the field of medical imaging and radiotherapy. CIRS is headquartered in Norfolk, VA (USA) and distributes products worldwide.
Reference:D. Pfeiffer, S. Sutlief, W. Feng, H. Pierce, J. Kofler, “AAPM Task Group 128: Quality assurance tests for prostate brachytheraphy ultrasound systems,” Med. Phys. 35(12), 5471-5489 (2008).
CIRS Sales and Marketing Manager